Tag M.D.

FDA: Over-the-Counter Asthma Inhalers Containing Chloroflouorocarbons (CFCs) Will No Longer be Made or Sold After Dec. 31, 2011

Sep22

WASHINGTON, Sept. 22 The U.S. Department of Health and Human Services’ Food and Drug Administration issued the following news release:The U.S. Food and Drug Administration says users of epinephrine inhalers containing chlorofluorocarbons (CFCs) should plan now to get a prescription for a replacement product because these inhalers will not be made or sold after Dec. […]

Echo Therapeutics to Present at the JMP Securities Healthcare Conference

Sep20

PHILADELPHIA, Sept. 20, 2011 /PRNewswire/ Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present […]

Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial

Sep19

ANN ARBOR, Mich., Sept. 19, 2011 /PRNewswire/ Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that the 150th patient has been enrolled in the randomized, double-blind, placebo-controlled, multi-center clinical trial of its Trimesta? (oral estriol) drug candidate for relapsing-remitting multiple sclerosis (MS) in women, per […]

Echo Therapeutics Receives Registered Trademarks for Symphony and Prelude

Sep15

PHILADELPHIA, Sept. 15, 2011 /PRNewswire/ Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced that the company has received Certificates of Registration from the United States Patent and Trademark Office […]

CORRECTING and REPLACING Magellan Health Services Receives International Award for Suicide Prevention in Central Arizona

Sep15

Rate of suicide deaths among people with serious mental illness in Central Arizona has decreased by 42 percent since 2007 PHOENIX(BUSINESS WIRE) Subhead of press release should read: Rate of suicide deaths among people with serious mental illness in Central Arizona has decreased by 42 percent since 2007 (sted Suicide deaths and psychiatric hospitalizations have […]

AmeriHealth Mercy Family of Companies to Give Physicians Innovative Mobile Technology and Information Delivery to Improve Care Management and Drug Adherence for At-Risk Patients

Sep13

Leading Medicaid Health Plan to Offer Physicians Handheld Devices, Mobile Clinical Alerts and e-Prescribing to Engage Patients at Point-of-Care and Reduce Hospitalizations and Health Care Costs BOSTON(BUSINESS WIRE) The AmeriHealth Mercy Family of Companies, one of the largest organizations of Medicaid managed care plans in the country, covering four million lives, today announced that it […]

Magellan Health Services ICORE Hosts 8th Annual Oncology Summit

Sep12

Oncology leaders to discuss key issues and the latest emerging trends NEW YORK(BUSINESS WIRE) Several leading oncology authorities will meet this Friday, September 16, at ICORE Healthcare’s 8th Annual Oncology Summit to discuss the latest trends and issues impacting oncology care, including health care reform, drug pipeline, genetic testing advances and changes in the payor […]

Magellan’s Meghan Dierks, M.D., to Join FDA Public Workshop Panel on Mobile Health Care Applications

Sep12

WASHINGTON(BUSINESS WIRE) Magellan Health Services Inc. (NASDAQ: MGLN) announced today that Meghan Dierks, M.D., vice president of clinical informatics, will serve as a panelist for the U.S. Food and Drug Administration’s (FDA) Public Workshop on its Mobile Medical Applications Draft Guidance, taking place in Washington, D.C. on September 12 and 13. According to the FDA, […]

Echo Therapeutics Initiates Clinical Trial of its Symphony Continuous Glucose Monitoring System

Sep8

PHILADELPHIA, Sept. 8, 2011 /PRNewswire/ Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony? tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude? SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System. The company expects to complete […]

Echo Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference

Sep7

PHILADELPHIA, Sept. 7, 2011 /PRNewswire/ Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony? tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude? SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present […]